Leveraging Paranasal, Chest CT in Severe Asthma
Paranasal and thoracic CT were useful to detect clinically important factors associated with poor asthma control in patients with severe asthma.
Home
Opioids Infrequently Prescribed for Severe Breathlessness in COPD and ILD
Hospitalized patients with COPD or interstitial lung disease are not frequently prescribed opioids for severe breathlessness, and those who are prescribed opioids for breathlessness do not receive timely follow-up.
Study to Assess Antiviral Antibody Cocktail for COVID-19 Prevention Begins
A phase 3 trial evaluating an investigational antiviral antibody cocktail, REGN-COV2, for the prevention of COVID-19 has been initiated by Regeneron Pharmaceuticals.
Asthma and COPD Health Expenditures Considerable in US Workers
Among the estimated 166 million US workers, 8 and 7 million had at least 1 asthma-related and at least 1 COPD-related medical event, respectively, between 2011 and 2015.
USPSTF Advises Annual Low-Dose CT Lung Screening for High-Risk Individuals
Annual CT screening recommended for patients aged 50 to 80 years at high risk for lung cancer from smoking.
Outcomes Similar in COVID-19 for Patients With or Without HIV
The rate of patients who required mechanical ventilation and died was similar between patients with HIV and matched comparators.
EAACI Guidelines for the Use of Biologic Therapies in Severe Asthma
Targeted therapy with 1 of 5 available biologic medications may effectively manage severe asthma.
Siltuximab to Be Evaluated for COVID-19 Associated ARDS in Phase 3 Trial
Siltuximab is currently marketed under the trade name Sylvant and is indicated for the treatment of multicentric Castleman’s disease.
ASAIO Recommendations for Advanced Cardiopulmonary Support for Patients With COVID-19
Recommendations by ASAIO on selection and treatment of patients with respiratory and circulatory failure associated with COVID-19 using artificial pulmonary and/or cardiac support.
Asthma Impairment and Risk Questionnaire Appropriate to Identify Asthma Control
The Asthma Impairment and Risk Questionnaire was deemed an appropriate measure to identify asthma control status in adults and adolescents that had been validated in a rigorous fashion.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Asthma
